-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PB-101 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PB-101 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PB-101 in Solid Tumor Drug Details: PB-101 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PB-119 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PB-119 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PB-119 in Type 2 Diabetes Drug Details: PB-119 (ExC39PEG23kDa) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PB-718 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PB-718 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PB-718 in Type 2 Diabetes Drug Details: PB-718 is under development...
-
Product Insights
NewPopulation Bio Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Population Bio Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Population Bio Inc (PB), formerly Population Diagnostics Inc is a gene discovery company that develops DNA-based diagnostics and personalized medicine tests. The company performs research, development and discovery of platform technology for validation of causative genetic biomarkers. Its RationalCNV analysis offers medical relevance to variants of unknown significance and novel variants. PB develops various therapies such as novel targeted...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AlphaMedix in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AlphaMedix in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AlphaMedix in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drug Details: AlphaMedix...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VMT-a-NET in Neuroendocrine Tumors
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VMT-a-NET in Neuroendocrine Tumors report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VMT-a-NET in Neuroendocrine Tumors Drug Details: VMT-a-NET is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VMT-a-NET in Medullary Thyroid Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VMT-a-NET in Medullary Thyroid Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VMT-a-NET in Medullary Thyroid Cancer Drug Details: VMT-a-NET is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VMT-a-NET in Pheochromocytoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VMT-a-NET in Pheochromocytoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VMT-a-NET in Pheochromocytoma Drug Details: VMT-a-NET is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bentracimab in Bleeding And Clotting Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bentracimab in Bleeding And Clotting Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bentracimab in Bleeding And Clotting Disorders Drug Details: Bentracimab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VMT-a-NET in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VMT-a-NET in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VMT-a-NET in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drug Details: VMT-a-NET...